Evidence map›Paper›PMID 24876814›Full record

ReviewContemporary oncology (Poznan, Poland)2014

The diagnostics of colorectal cancer.

Magdalena Swiderska, Barbara Choromańska, Ewelina Dąbrowska, Emilia Konarzewska-Duchnowska, Katarzyna Choromańska, Grzegorz Szczurko, Piotr Myśliwiec, Jacek Dadan, Jerzy Robert Ladny, Krzysztof Zwierz

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Contemporary oncology (Poznan, Poland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Magdalena SwiderskaDepartment of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
Barbara Choromańska1 Department of General and Endocrinological Surgery, Medical University of Bialystok, Bialystok, Poland.
Ewelina DąbrowskaDepartment of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland.
Emilia Konarzewska-DuchnowskaDepartment of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland.
Katarzyna ChoromańskaSKN Dental Biochemistry at the Department of Conservative Dentistry, Medical University of Bialystok, Bialystok, Poland.
Grzegorz SzczurkoDepartment of Restorative Dentistry, Medical University of Bialystok, Bialystok, Poland.
Piotr Myśliwiec1 Department of General and Endocrinological Surgery, Medical University of Bialystok, Bialystok, Poland.
Jacek Dadan1 Department of General and Endocrinological Surgery, Medical University of Bialystok, Bialystok, Poland.
Jerzy Robert LadnyDepartment of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland.
Krzysztof ZwierzMedical College of the Universal Education Society, Lomza, Poland.
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most frequent human malignant neoplasms. CRC has an estimated incidence of more than 1,000,000 new cases annually worldwide. Approximately one out of three people who develop CRC dies from the disease. Furthermore, CRC often affects inhabitants of industrialized countries in comparison to less developed countries. Several markers of colon cancer, including CEA, CA-19-9, TPS, TAG-72 and lysosomal hydrolases, have been identified and are now being adopted in routine clinical practice. Increased values of these markers are often the first signal of recurrence or metastases, which is useful in prediction and prognosis of clinical outcome of patients with CRC. Determination of the activity of lysosomal exoglycosidases in body fluids may bring some hope of improving diagnosis of colorectal cancer. However, it has to be remembered that currently the most effective diagnostic method of CRC is endoscopy.

Indexed as

colorectal cancerendoscopylysosomal exoglycosidasestumor markers

Identifiers

PMID24876814
PMCPMC4037991
OpenAlexW2161032033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.